GGrantIndex
Sort

25,944 grants matching neurodegeneration

HIV Effects on Astrocyte Function and Astrocyte-Neuronal Interactions

$212,497
St. Luke'S-Roosevelt Inst For Hlth Scis · P01 · FY2004 · NS

Exploring FOXO Signaling in Promoting Neurodegeneration in AD

$212,463
Kavita Shah · Purdue University · R21 · FY2014 · AG

Developing Hyperpolarized Nitrogen-15 MRI Agents for Probing Glutamine Metabolism

$212,408
Qiu Wang · Duke University · R21 · FY2025 · EB

Mechanisms of Intercellular Communication

$212,298
Albert Einstein Col Of Med Yeshiva Univ · T32 · FY2004 · NS

Imaging Calpain/Bioenergetic Interactions in Neuronal Excitotoxicity

$212,188
Brian M Polster · Buck Institute For Research On Aging · R21 · FY2007 · NS

Generation of trisomy 21 induced pluripotent stem cells

$212,080
Anita Bhattacharyya · University Of Wisconsin-Madison · R21 · FY2009 · HD

UAB Training Program in Neurodegeneration

$212,055
Erik D Roberson · University Of Alabama At Birmingham · T32 · FY2023 · NS

MECHANISMS FOR GLUTAMATE TRANSPORTER ALTERATIONS IN ALZH

$212,034
Ohio State University · R01 · FY2002 · MH

CATECHOLAMINES IN AGING AND OXIDATIVE STRESS

$211,963
Paula C Bickford · University Of South Florida · P01 · FY2007 · AG

Dietary glycomacropeptide (GMP) for neuroprotection and cognitive enhancement

$211,920
Michael P McDonald · University Of Tennessee Health Sci Ctr · R21 · FY2012 · AG

Multiscale Modeling of Brain Aging and Alzheimer’s Disease with MRI, Pathology and Proteomics

$211,875
Els Fieremans · New York University School Of Medicine · R21 · FY2025 · AG

The role of NBEAL2 in the cornea

$211,875
Shukti Chakravarti · New York University School Of Medicine · R21 · FY2021 · EY

Metabolomics of the Endosomal/Lysosomal System

$211,875
Yiannis A Ioannou · Icahn School Of Medicine At Mount Sinai · R21 · FY2010 · NS

High-throughput screening assay development for axonopathic neurodegeration

$211,875
Norbert Perrimon · Harvard Medical School · R21 · FY2006 · NS

Modulators of Rab9 Expression for the Treatment of Niemann-Pick C Disease

$211,875
Yiannis A Ioannou · Icahn School Of Medicine At Mount Sinai · R21 · FY2010 · NS

A modified dietary regiment as a potential novel therapeutic intervention in ALS.

$211,875
Giulio Maria Pasinetti · Icahn School Of Medicine At Mount Sinai · R21 · FY2007 · AT

Chemical chaperones for Niemann-Pick C disease

$211,875
Yiannis A Ioannou · Icahn School Of Medicine At Mount Sinai · R21 · FY2006 · DK

MECHANISMS OF PATHOLOGICAL NEURITIC &SOMAL DEGENERATION

$211,844
University Of California Irvine · R01 · FY2001 · AG

PATHOLOGY

$211,727
Stephen J. Dearmond · University Of California, San Francisco · P01 · FY2012 · AG

Genetics

$211,631
Daniel H Geschwind · University Of California, San Francisco · P01 · FY2013 · AG

Role of IgA-biome in intestinal dysbiosis and brain changes in Alzheimer's disease

$211,500
Suba Nookala · University Of North Dakota · R21 · FY2023 · AG

The Clathrin Coated Vesicle Cycle

$211,438
Sandra L. Schmid · Ut Southwestern Medical Center · R01 · FY2012 · MH

U.S./Costa Rica Neuropsychiatric Genetics Research Training Program

$211,435
Michael A Escamilla · Texas Tech University Health Scis Center · D43 · FY2013 · TW

AUTOMATED IMAGE ANALYSIS OF HUMAN BRAIN CELLS

$211,362
University Of California Irvine · R01 · FY2000 · AG

SK Channel Openers as Therapeutics for Cerebellar Ataxia

$211,298
Heike Wulff · University Of California At Davis · R21 · FY2006 · NS